Monoclonal antibody discovery mice

Trianni has developed transgenic immunoglobulin mice capable of expressing the full human antibody repertoire, ideal for the discovery of new therapeutic antibody candidates.

Like 2 Comment
Page of
Go to the profile of Trianni


Trianni, Inc. is a biotech company specializing in human antibody discovery platform technology. Our existing asset is a cutting-edge platform enabling efficient discovery of fully-human monoclonal antibodies.

No comments yet.